Items where Author is "Ayromlou, H."
 | Up a level |
Article
(2024) Efficacy and safety of peginterferon beta-1a compared to interferon beta-1a in relapsing remitting multiple sclerosis patients: A phase 3, randomized, non-inferiority clinical trial (PEGINTEGRITY). Multiple Sclerosis and Related Disorders. p. 8. ISSN 2211-0348
(2024) Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial. Scientific Reports. p. 12. ISSN 2045-2322
(2023) Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study. Archives of Iranian Medicine. pp. 647-653. ISSN 1029-2977
(2021) Pregnancy outcome in patients with multiple sclerosis treated with Rituximab: A case-series study. Multiple Sclerosis and Related Disorders. ISSN 2211-0348
(2021) Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study. CASPIAN JOURNAL OF INTERNAL MEDICINE. S491-S494. ISSN 2008-6164 2008-6172 J9 - CASP J INTERN MED
(2021) An interdependence between GAPVD1 gene polymorphism, expression level and response to interferon beta in patients with multiple sclerosis. Journal of Neuroimmunology. ISSN 0165-5728
(2020) Connection of miR-185 and miR-320a expression levels with response to interferon-beta in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. ISSN 2211-0348
(2020) miR-504 expression level is increased in multiple sclerosis patients responder to interferon-beta. Journal of Neuroimmunology. ISSN 0165-5728
(2017) Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations. Multiple Sclerosis and Related Disorders. pp. 144-151. ISSN 2211-0348
(2015) Amyotrophic lateral sclerosis progression: Iran-ALS clinical registry, a multicentre study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. pp. 506-511. ISSN 2167-8421